Read the latest positive news, breakthroughs, and inspiring stories about biotech, curated daily by BrightWire.
An MIT startup has created a bioadhesive that sticks to wet tissue in seconds, making complex surgical stitching as simple as applying tape. The technology could transform dozens of procedures from heart bypasses to C-sections while reducing complications and costs.
Massachusetts' biotech industry is recovering after losing 3,600 jobs in 2025, its first workforce decline in over two decades. The sector that powers life-saving drug discoveries is showing signs of renewal in 2026.
A biotech entrepreneur is celebrating two major victories: his early research helped transform pancreatic cancer treatment, and his new company just raised $263 million to develop drugs for organ transplants and autoimmune diseases.
A Bangalore company is using artificial intelligence to predict which drug candidates will fail before years of lab work are wasted. Their first discovery is now ready for clinical trials targeting a rare muscle disease.
A new biotech company just launched with $230 million to develop a one-time cure for a genetic disease affecting thousands. Serapha Bio aims to fix the root cause of Alpha-1 Antitrypsin Deficiency using cutting-edge gene editing.
A crowdfunded nonprofit called Foregen is developing a way to reverse circumcision using tissue engineering and a patient's own stem cells. Human clinical trials could begin soon after 15 years of research and development.
A startup founded by plant science researchers is creating the world's first at-home test to detect chromosomal abnormalities as early as six weeks into pregnancy. The India-based company just won top honors at a major tech summit, bringing affordable prenatal care to families worldwide.
A biotech company focused on reversing aging just raised $435 million to test its first medicine in humans. NewLimit will begin clinical trials on a liver treatment that could help people live healthier, longer lives.
A tiny medical device from Ahmedabad is making delicate blood vessel surgery possible for doctors without years of specialized training. The innovation could prevent countless amputations in hospitals that lack surgical specialists.
A startup just cracked one of science's toughest problems: growing baby birds entirely outside their shells. The breakthrough could bring extinct species like the dodo back to life.
After a difficult year, biotech company Sarepta Therapeutics is bouncing back with early clinical trial results showing two new muscular dystrophy treatments appear safe and effective. The promising data offers hope for patients with rare muscle-wasting diseases who desperately need new treatment options.
A powerful group of European venture capital firms just launched a coalition to unlock more funding for life sciences startups across the continent. The move tackles one of Europe's biggest challenges in biotech innovation.